Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Post-transcriptional Regulation of De Novo Lipogenesis by mTORC1-S6K1-SRPK2 Signaling.

Cell | 2017

mTORC1 is a signal integrator and master regulator of cellular anabolic processes linked to cell growth and survival. Here, we demonstrate that mTORC1 promotes lipid biogenesis via SRPK2, a key regulator of RNA-binding SR proteins. mTORC1-activated S6K1 phosphorylates SRPK2 at Ser494, which primes Ser497 phosphorylation by CK1. These phosphorylation events promote SRPK2 nuclear translocation and phosphorylation of SR proteins. Genome-wide transcriptome analysis reveals that lipid biosynthetic enzymes are among the downstream targets of mTORC1-SRPK2 signaling. Mechanistically, SRPK2 promotes SR protein binding to U1-70K to induce splicing of lipogenic pre-mRNAs. Inhibition of this signaling pathway leads to intron retention of lipogenic genes, which triggers nonsense-mediated mRNA decay. Genetic or pharmacological inhibition of SRPK2 blunts de novo lipid synthesis, thereby suppressing cell growth. These results thus reveal a novel role of mTORC1-SRPK2 signaling in post-transcriptional regulation of lipid metabolism and demonstrate that SRPK2 is a potential therapeutic target for mTORC1-driven metabolic disorders.

Pubmed ID: 29153836 RIS Download

Additional research tools detected in this publication

Associated grants

  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL121266
  • Agency: NCI NIH HHS, United States
    Id: R01 CA046595
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL138481
  • Agency: NIA NIH HHS, United States
    Id: R01 AG054215
  • Agency: NCI NIH HHS, United States
    Id: P01 CA120964
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK098331
  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM114160
  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK036836
  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM051405
  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM041890
  • Agency: NCI NIH HHS, United States
    Id: R01 CA163591
  • Agency: NCI NIH HHS, United States
    Id: R35 CA197588
  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM062891
  • Agency: NIGMS NIH HHS, United States
    Id: R35 GM122610
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL098216
  • Agency: NCI NIH HHS, United States
    Id: P30 CA016359

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


New England Biolabs (tool)

RRID:SCR_013517

An Antibody supplier

View all literature mentions

Adobe Photoshop (tool)

RRID:SCR_014199

Software for image processing, analysis, and editing. The software includes features such as touch capabilities, a customizable toolbar, 2D and 3D image merging, and Cloud access and options.

View all literature mentions

Anti-U1-70k (antibody)

RRID:AB_887903

This monoclonal targets U1-70k

View all literature mentions

SREBP-1 (H-160) (antibody)

RRID:AB_2194223

This polyclonal targets SREBF1

View all literature mentions

Lamin A/C (N-18) (antibody)

RRID:AB_648152

This polyclonal targets LMNA

View all literature mentions

GST (Z-5) (antibody)

RRID:AB_631586

This polyclonal targets GST (Z-5)

View all literature mentions

Actin (C-11) (antibody)

RRID:AB_630835

This polyclonal targets ACTG1, ACTC1, ACTA1, ACTA2, ACTG2, ACTB

View all literature mentions

SF2/ASF Antibody (96) (antibody)

RRID:AB_628248

This monoclonal targets SF2/ASF

View all literature mentions

FDFT1 antibody [EPR4626] (antibody)

RRID:AB_10859772

This monoclonal targets FDFT1 antibody [EPR4626]

View all literature mentions

Monoclonal Anti-GAPDH antibody produced in mouse (antibody)

RRID:AB_1078991

This monoclonal targets GAPDH antibody produced in mouse

View all literature mentions

V5-Tag (D3H8Q) Rabbit Antibody (antibody)

RRID:AB_2687461

This monoclonal targets V5-Tag

View all literature mentions

Phospho-p70 S6 Kinase (Thr389) (108D2) Rabbit mAb (antibody)

RRID:AB_2269803

This monoclonal targets p70 S6 Kinase, phospho (Thr389)

View all literature mentions

Phospho-S6 Ribosomal Protein (Ser240/244) (D68F8) XP Rabbit mAb (antibody)

RRID:AB_10694233

This monoclonal targets Phospho-S6 Ribosomal Protein (Ser240/244) (D68F8) XP Rabbit mAb

View all literature mentions

Phospho-S6 Ribosomal Protein (Ser235/236) Antibody (antibody)

RRID:AB_331679

This polyclonal targets Phospho-S6 Ribosomal Protein (Ser235/236)

View all literature mentions

S6 Ribosomal Protein (54D2) Mouse mAb (antibody)

RRID:AB_2238583

This monoclonal targets S6 Ribosomal Protein (54D2) Mouse mAb

View all literature mentions

Fatty Acid Synthase (C20G5) Rabbit mAb (antibody)

RRID:AB_2100796

This monoclonal targets Fatty Acid Synthase

View all literature mentions

ATP-Citrate Lyase Antibody (antibody)

RRID:AB_2223744

This polyclonal targets Acly

View all literature mentions

MAb104 (cell line)

RRID:CVCL_G668

Cell line MAb104 is a Hybridoma with a species of origin Mus musculus

View all literature mentions

DLD-1 (cell line)

RRID:CVCL_0248

Cell line DLD-1 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

RT-4 (cell line)

RRID:CVCL_0036

Cell line RT-4 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions